DZ1766A1 - Inhibiteurs de vih protéase utiles pour le traitement du sida. - Google Patents

Inhibiteurs de vih protéase utiles pour le traitement du sida.

Info

Publication number
DZ1766A1
DZ1766A1 DZ940030A DZ940030A DZ1766A1 DZ 1766 A1 DZ1766 A1 DZ 1766A1 DZ 940030 A DZ940030 A DZ 940030A DZ 940030 A DZ940030 A DZ 940030A DZ 1766 A1 DZ1766 A1 DZ 1766A1
Authority
DZ
Algeria
Prior art keywords
treatment
aids
protease inhibitors
compounds
hiv protease
Prior art date
Application number
DZ940030A
Other languages
English (en)
Inventor
Joseph P Vacca
James P Guare
Bruce D Dorsey
M Katharine Holloway
Randall W Hungate
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DZ1766A1 publication Critical patent/DZ1766A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
DZ940030A 1993-03-31 1994-03-30 Inhibiteurs de vih protéase utiles pour le traitement du sida. DZ1766A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31

Publications (1)

Publication Number Publication Date
DZ1766A1 true DZ1766A1 (fr) 2002-02-17

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ940030A DZ1766A1 (fr) 1993-03-31 1994-03-30 Inhibiteurs de vih protéase utiles pour le traitement du sida.

Country Status (35)

Country Link
EP (1) EP0617968B1 (fr)
JP (1) JPH08508496A (fr)
KR (1) KR100311551B1 (fr)
CN (1) CN1090186C (fr)
AT (1) ATE230610T1 (fr)
AU (1) AU685772B2 (fr)
BG (1) BG62083B1 (fr)
BR (1) BR9406503A (fr)
CA (1) CA2120192A1 (fr)
CY (1) CY2326B1 (fr)
CZ (1) CZ286412B6 (fr)
DE (1) DE69431972T2 (fr)
DK (1) DK0617968T3 (fr)
DZ (1) DZ1766A1 (fr)
ES (1) ES2188604T3 (fr)
FI (1) FI954580A0 (fr)
HK (1) HK1009248A1 (fr)
HR (1) HRP940209B1 (fr)
HU (1) HUT74006A (fr)
IL (1) IL109166A (fr)
LV (1) LV13141B (fr)
NO (1) NO953876L (fr)
NZ (1) NZ265164A (fr)
PL (1) PL310895A1 (fr)
PT (1) PT617968E (fr)
RO (1) RO118000B1 (fr)
RU (1) RU2139052C1 (fr)
SA (1) SA94140745B1 (fr)
SG (1) SG64366A1 (fr)
SI (1) SI9420017B (fr)
SK (1) SK279471B6 (fr)
TW (1) TW307684B (fr)
WO (1) WO1994022480A1 (fr)
YU (1) YU49275B (fr)
ZA (1) ZA942255B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74681A (en) * 1993-12-15 1997-01-28 Merck & Co Inc N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
EP0785786A4 (fr) * 1994-10-25 1998-01-28 Merck & Co Inc Synthese microbienne d'inhibiteurs de la protease du vih
US6689761B1 (en) * 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
WO2000002862A1 (fr) 1998-07-08 2000-01-20 G.D. Searle & Co. Inhibiteurs de la protease retrovirale
WO2000021565A1 (fr) * 1998-10-13 2000-04-20 Du Pont Pharmaceuticals Company Eradication selective des cellules infectees par des virus par l'utilisation combinee d'un agent cytotoxique et d'un agent antiviral
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
WO2006019831A1 (fr) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Procedes pour le traitement de l'hepatite c
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するためのチエノピリジン
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021647A1 (fr) * 1991-06-04 1992-12-10 Smithkline Beecham Corporation Inhibiteurs carbocycliques et heterocycliques de la protease du hiv

Also Published As

Publication number Publication date
YU49275B (sh) 2005-03-15
RO118000B1 (ro) 2002-12-30
DK0617968T3 (da) 2003-02-24
DE69431972D1 (de) 2003-02-13
PL310895A1 (en) 1996-01-08
KR960701661A (ko) 1996-03-28
FI954580A (fi) 1995-09-27
NO953876D0 (no) 1995-09-29
SK279471B6 (sk) 1998-11-04
CN1090186C (zh) 2002-09-04
CZ252895A3 (en) 1996-07-17
BG100016A (en) 1996-04-30
SI9420017A (en) 1996-10-31
SI9420017B (sl) 2003-12-31
CN1120316A (zh) 1996-04-10
CY2326B1 (en) 2003-11-14
IL109166A0 (en) 1994-06-24
DE69431972T2 (de) 2003-08-28
AU685772B2 (en) 1998-01-29
NZ265164A (en) 1997-09-22
SK122595A3 (en) 1997-03-05
CZ286412B6 (en) 2000-04-12
EP0617968A1 (fr) 1994-10-05
KR100311551B1 (ko) 2001-12-28
HUT74006A (en) 1996-10-28
IL109166A (en) 1999-08-17
ZA942255B (en) 1994-11-01
NO953876L (no) 1995-11-30
ATE230610T1 (de) 2003-01-15
CA2120192A1 (fr) 1994-10-01
PT617968E (pt) 2003-03-31
FI954580A0 (fi) 1995-09-27
JPH08508496A (ja) 1996-09-10
HRP940209A2 (en) 1998-02-28
AU5921394A (en) 1994-10-06
WO1994022480A1 (fr) 1994-10-13
SG64366A1 (en) 1999-04-27
SA94140745B1 (ar) 2006-07-11
YU15994A (sh) 1999-06-15
LV13141B (en) 2004-08-20
ES2188604T3 (es) 2003-07-01
HU9502860D0 (en) 1995-11-28
BR9406503A (pt) 1996-01-02
BG62083B1 (bg) 1999-02-26
HRP940209B1 (en) 2004-04-30
RU2139052C1 (ru) 1999-10-10
HK1009248A1 (en) 1999-05-28
TW307684B (fr) 1997-06-11
EP0617968B1 (fr) 2003-01-08

Similar Documents

Publication Publication Date Title
DZ1766A1 (fr) Inhibiteurs de vih protéase utiles pour le traitement du sida.
DE69228106D1 (de) HIV-Protease-Inhibitoren
IN172553B (fr)
DE69531944D1 (de) Neue hiv-protease-inhibitoren
DE69430385D1 (de) Hiv-proteaseinhibitoren
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.